| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.00B | 59.51B | 55.99B | 57.88B | 56.75B | 69.38B |
| Gross Profit | 15.13B | 15.47B | 14.82B | 16.24B | 13.08B | 13.43B |
| EBITDA | 9.05B | 4.16B | 8.12B | 9.28B | 5.47B | 6.31B |
| Net Income | 3.06B | 2.62B | 3.09B | 4.71B | 252.00M | 2.25B |
Balance Sheet | ||||||
| Total Assets | 100.47B | 100.00B | 100.42B | 92.11B | 86.54B | 82.10B |
| Cash, Cash Equivalents and Short-Term Investments | 2.85B | 2.97B | 4.91B | 3.78B | 6.07B | 5.34B |
| Total Debt | 25.19B | 26.93B | 29.47B | 31.43B | 30.60B | 26.03B |
| Total Liabilities | 64.73B | 60.70B | 65.08B | 59.76B | 57.78B | 53.23B |
| Stockholders Equity | 34.27B | 37.78B | 33.91B | 30.94B | 25.11B | 25.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.55B | -1.32B | -2.32B | -3.70B | 1.90B |
| Operating Cash Flow | 0.00 | 8.31B | 7.17B | 5.70B | 2.09B | 4.09B |
| Investing Cash Flow | 0.00 | -4.41B | -8.56B | -8.50B | -5.59B | -548.00M |
| Financing Cash Flow | 0.00 | -5.75B | 2.38B | 463.00M | 4.14B | -1.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥435.88B | 10.13 | 6.90% | 2.71% | 1.04% | 110.81% | |
74 Outperform | ¥76.67B | 12.05 | ― | 6.64% | 1.64% | -3.80% | |
72 Outperform | ¥32.02B | 6.58 | ― | 6.14% | -5.39% | 50.53% | |
70 Outperform | ¥135.57B | 4.25 | 10.46% | 2.35% | 2.18% | 84.02% | |
69 Neutral | ¥56.63B | 9.03 | ― | 3.31% | 2.25% | 30.32% | |
68 Neutral | ¥12.10B | 5.16 | ― | 1.95% | 6.28% | -15.61% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |